Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Classifications
Explore trials based on treatment classification/type.
Targets
Explore trials based on treatment targets.
MSK Service
Filter trials based on MSK Service
Not yet accepting
CARTITUDE-2
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
Learn more- CAR T Cell
- BCMA
- Phase 2
- Myeloma Service
- 21-009
Accepting patients
RedirecTT-1
A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection Antibodies Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- GPRC5D
- Phase 1/2
- Myeloma Service
- 23-259
Accepting patients
Investigational Cord Blood Units
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Program (NCBP) for Unrelated Transplantation
Learn more- Allogeneic Stem Cell Transplant
- Cord Blood
- Phase 2
- Transplant Service
Accepting patients
CaMMouflage
A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage Trial)
Learn more- CAR T Cell (Allogeneic)
- BCMA
- Phase 1
- Myeloma Service
- 23-182
Accepting patients
GPC-100
A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Learn more- Randomization
- Phase 2
- Myeloma Service